The AISN partners gathered for their 8th General Assembly meeting, a two-day event (October 28-29) dedicated to reviewing the project’s latest progress and next steps. The discussions focused on the ongoing activities across all work packages and the overall project timeline.
A special highlight of the meeting was the current clinical trial phase, where partners exchanged insights on implementation, data collection, and user feedback from both patients and healthcare professionals. The meeting fostered productive collaboration and reaffirmed the consortium’s shared commitment to advancing AI-driven solutions for stroke neurorehabilitation.